Search

everythinglearnresearchcommunity

for

Search:↓

Androgens may block hair growth signals, targeting this could treat hair loss.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Laser hair removal works well for people with dark hair and light skin, but it's less effective for light hair or dark skin; improvements are expected.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Early treatment helps stop hair loss in women of color.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Patients with mycosis fungoides have a higher risk of heart disease.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.